Target intelligence / Profile preview

Reactive oxygen species generation machinery (ROS generation machinery)

Target
ROS generation machinery
Molecular classification
Enzyme, Enzyme complex, Oxidoreductase
01

Overview

The reactive oxygen species (ROS) generation machinery encompasses a collection of enzymes and organelles that produce pro-oxidant molecules, primarily superoxide and hydrogen peroxide. Key components include the NADPH oxidase (NOX) family (NOX1-5, DUOX1-2), the mitochondrial electron transport chain (specifically Complexes I and III), xanthine oxidase, and cytochrome P450 enzymes (Bedard & Krause, 2007; Murphy, 2009). Under physiological conditions, these systems generate ROS that act as vital signaling molecules for cell growth, differentiation, and the immune response (Lambeth, 2004). However, dysregulation of this machinery leads to excessive ROS production, resulting in oxidative stress and damage to cellular macromolecules, which is a hallmark of diseases such as atherosclerosis, hypertension, neurodegeneration, and cancer (Brand, 2016). Therapeutic strategies target specific elements of this machinery, such as NOX inhibitors (e.g., Setanaxib) or xanthine oxidase inhibitors (e.g., Allopurinol), to mitigate oxidative damage. A significant challenge in targeting this machinery is the need to selectively inhibit pathological ROS production without interfering with essential redox-mediated signaling pathways required for normal cellular function.

Other names
ROS-producing enzymesPro-oxidant machineryNADPH oxidase complexMitochondrial ROS sourcesOxidative stress machinery
02

Mechanism of action

Inhibition of NADPH oxidase (NOX) enzymes, inhibition of xanthine oxidase, or modulation of mitochondrial electron transport chain complexes to reduce the production of superoxide and hydrogen peroxide.

03

Biological functions

Signal transductionImmune responseApoptosisCell proliferationRedox homeostasisPhagocytosis
04

Disease associations

InflammationCancerCardiovascular diseaseNeurodegenerative diseaseDiabetesAtherosclerosis
05

Safety considerations

Impairment of innate immune response (e.g., phagocytic oxidative burst)Disruption of physiological redox signalingPotential for off-target toxicity due to broad enzyme inhibitionRisk of chronic granulomatous disease-like phenotype with NOX2 inhibition
06

Interacting drugs

Setanaxib (GKT137831)

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsNitrotyrosineF2-isoprostanes

Beyond the preview

Go deeper on Reactive oxygen species generation machinery (ROS generation machinery).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species generation machinery (ROS generation machinery).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call